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INTRODUCTION 
Antibiotic prophylaxis can prevent infection in contaminated wounds 
but are clearly not indicated for most patients undergoing straightforward clean 
surgical operations in which no obvious bacterial contamination or insertion of 
a foreign body has occurred. The infective complications of open 
cholecystectomy are well known, and prophylactic antibiotics are a routine 
practice. However, the wounds created after open cholecystectomy behave 
differently as compared to laparoscopic cholecystectomy. First, the wounds 
created are smaller as compared to the open surgery. Secondly, it has been 
proved that the immune system is better preserved in laparoscopic surgery 
since the tissue trauma is less.These results in lesser activation of the 
inflammatory response following the laparoscopic procedure. Furthermore, 
laparoscopic cholecystectomy per se does not violate the mucosal defense 
barrier of the respiratory, gastro-intestinal or genital epithelium. Observing the 
low incidence of infections following laparoscopic cholecystectomy, the need 
for antibiotics is now frequently questioned. The over-use of antibiotics can 
result in a rising frequency of adverse effects, emergence of drug resistant 
organisms, as well as increased cost. It is not clear whether antibiotic 
prophylaxis in laparoscopic cholecystectomy is of any advantage to the patient 
in terms of preventing infection. Thus, the present study was undertaken to 
evaluate the rate of infection in laparoscopic cholecystectomies, and to assess 
the usefulness and efficacy of antibiotic prophylaxis in laparoscopic 
cholecystectomy. 
  
 
 
AIMS AND OBJECTIVE 
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AIM 
To compare the impact of single dose of prophylactic intravenous 
antibiotic at induction of anaesthesia alone with intravenous antibiotic 
continued in the post operative period in terms of post-operative infection 
related complication. 
 
OBJECTIVE 
1. To avoid unnecessary long post operative antibiotic regimen 
2. To reduce the hospital cost hence we can improve the cost 
effectiveness 
3. To prevent antibiotic resistance 
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REVIEW OF LITERATURE 
HISTORICAL REVIEW 
Archaeological excavations demonstrating the presence of gallstones in 
young Egyptian women have confirmed that cholelithiasis has plagued 
mankind for over 2000 years.[1] 
Alexander of Tralles (525-605), a physician of the Byzantine Empire, 
was one of the first to mention gall stones, describing calculi in human livers.[2] 
Gordon Taylor (1937) suggested that the first clinical description of 
gallstone disease was recorded in the 4th century BC. Despite description of 
liver and gallbladder, recognition of the gallstones was not recorded until 5th 
century. Credit is given to Greek Physician Alexandra. His description of 
concretions within bile ducts is almost certainly that of  gallstones. 
Vesalius gave an accurate description of human gallstones, concluding 
that they represented a disease and describing some of their consequences. 
Joenisius was credited for the first successful cholecystolithotomy in 
1676, but the apparently extracted gallstones from a biliary fistula of the 
abdominal wall following spontaneous drainage of the abscess. 
Cholecystotomy was reported and recommended by Jean- Louis Petit in 
1743 after he had mistakenly opened the gall bladder when attempting to drain 
what he thought was an abdominal wall abscess. 
Nonetheless, the treatment for symptomatic gallstone disease remained 
relatively primitive and ineffective until the late 1800’s. As surgical techniques 
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began to evolve, John Bobbs, an Indian surgeon and others attempted to 
perform cholecystolithotomy, removing the stone from the gallbladder and 
leaving the organ in situ. [3] This proved to be effective in ameliorating acute 
symptoms, physicians were disappointed by the recurrence of symptoms in 
many of these patients. 
In 1882, Karl Langenbunch, a noted German surgeon performed the 
first successful cholecystectomy.[4] 
During the last 100 years, open cholecystectomy has remained the gold 
standard for the definitive management of patients with symptomatic 
cholelithiasis.[5] 
LAPAROSCOPIC CHOLECYSTECTOMY 
Although these advances had widespread rise of laparoscopy for 
diagnostic and stabilization procedures in gynecological surgery, few general 
surgeons used it on their surgical practice. The exceptions were pioneering 
individuals such as George Berci and Alfred Cushiri who used diagnostic 
laparoscopy for everlasting and staging patients with abdominal malignancies. 
In 1987, Philippe Mouret performed the first laparoscopic cholecystectomy in 
a human.[6]. Almost simultaneously Mc Kernan and Saye performed the first 
laparoscopic cholecystectomy in the United States in 1988.[7]In fact, in 1985, 
Prof. Erich Muhe of Boblingen, Germany had carried out the first laparoscopic 
cholecystectomy. He presented his technique at the Congress of the German 
Surgical Society.[8] Unfortunately, his technique was not appreciated by his 
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colleagues and did not become popular. His work was not realized until 1999, 
when he was recognized by SAGES for having performed the first 
laparoscopic cholecystectomy. The first laparoscopic cholecystectomy in India 
was performed in 1990 at the JJ Hospital, Mumbai, followed by few months 
later in Pune by Dr. Jyotsna Kulkarni. [9]Within a short span of five years 
laparoscopic cholecystectomy has surpassed conventional cholecystectomy as 
procedure of choice for diseases of gallbladder 
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SURGICAL SITE INFECTIONS: 
Surgical site infections (SSIs) are infections present in any location 
along the surgical tract after a surgical procedure. In 1992 the Surgical Wound 
Infection Task Force published a new set of definitions for wound infections 
that included changing the term to SSI. Unlike surgical wound infections, SSIs 
involve postoperative infections occurring at any level (incisional or deep) of a 
specific procedure. SSIs are divided into incisional superficial (skin, 
subcutaneous tissue), incisional deep (fascial plane and muscles), and 
organ/space related (anatomic location of the procedure itself).Examples of 
organ/space SSIs include intra-abdominal abscesses, empyema, and 
mediastinitis. SSIs are the most common nosocomial infection in our 
population and constitute 38% of all infections in surgical patients. By 
definition, they can occur anytime from 0 to 30 days after the operation or up to 
1 year after a procedure that has involved the implantation of a foreign material 
(mesh, vascular graft, prosthetic joint, and so on). Incisional infections are the 
most common; they account for 60% to 80% of all SSIs and have a better 
prognosis than organ/space-related SSIs do, with the latter accounting for 93% 
of SSI-related mortalities. 
Understanding the microbiology of SSIs is important to guide initial 
empirical therapy for infections in a specific patient, as well as for 
identification of outbreaks and selection of strategies for the management of 
prophylactic antibiotics. 
7 
Surgical site infections (SSIs) are a real risk associated with any surgical 
procedure and represent a significant burden in terms of patient morbidity and 
mortality, and cost to health services around the world. Surgical wound 
infection is a common postoperative complication and causes significant 
postoperative morbidity and mortality, prolongs hospital stay, and adds 
between 10% and 20% to hospital costs. 
Surgical site infections are the 3rd most common post op infection in 
surgical patients after urinary tract and respiratory tract infections. Surgical site 
infections are usually secondary to inoculation of bacteria from patients own 
endoflora (eg. Anterior nares, mouth, rectum) and less often from the 
environment. 
 
Definition of SSI 
Any purulent discharge from a closed surgical incision, together with 
signs of inflammation of the surrounding tissue should be considered as wound 
infection, irrespective of whether micro-organisms can be cultured. Infection 
can occur at an incision site within 30 days of an operation, but if an implant is 
placed (eg. Arthroplasty, mesh) the definition is extended upto 1 year. There 
are intermediate categories of wounds that may or may not be infected— 
namely, wounds that have a small amount of clear discharge. These wounds 
maybe considered as 'possibly' or 'probably' infected. In 1992, the Surgical 
Wound Infection Task Force replaced the term 'surgical wound infection' with 
‘surgical site infection', to include infections of organs or spaces deep in the 
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skin and soft tissues, such as peritoneum and bone. Surgical site infection is 
classified into superficial site infection and organ or space infection. 
Types of SSI  
• Superficial Incisional SSI 
• Deep Incisional SSI 
• Organ / Space SSI 
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CRITERIA FOR DEFINING A SURGICAL SITE INFECTION (SSI) 
Superficial Incisional SSI 
Infection occurs within 30 days after the operation and Infection 
involves only skin or subcutaneous tissue of the incision and at least one of the 
following: 
1. Purulent drainage, with or without laboratory confirmation, from the 
superficial incision. 
2. Organisms isolated from an aseptically obtained culture of fluid or 
tissue from the 
superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat and superficial incision is 
deliberately opened by surgeon, unless incision is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending 
physician.  
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal inflammation and discharge confined to the 
points of suture penetration). 
2. Infection of an episiotomy or newborn circumcision site. 
3. Infected burn wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see 
deep incisional SSI). 
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Deep Incisional SSI 
Infection occurs within 30 days after the operation if no implant† is left 
in place or within 1 year if implant is in place and the infection appears to be 
related to the operation and infection involves deep soft tissues (e.g., fascial 
and muscle layers) of the incision and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space 
component of the surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a 
surgeon when the patient has at least one of the following signs or symptoms: 
fever (>38ºC), localized pain, or tenderness, unless site is culture-negative. 
3. An abscess or other evidence of infection involving the deep incision 
is found on direct examination, during reoperation, or by histopathologyic or 
radiologic examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending 
physician. 
Notes: 
1. Report infection that involves both superficial and deep incision sites 
as deep incisional SSI. 
2. Report an organ/space SSI that drains through the incision as a deep 
incisional SSI. 
Organ/Space SSI 
Infection occurs within 30 days after the operation if no implant† is left 
in place or within 1 year if implant is in place and the infection appears to be 
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related to the operation and infection involves any part of the anatomy (e.g., 
organs or spaces), other than the incision, which was opened or manipulated 
during an operation and atleast one of the following: 
1. Purulent drainage from a drain that is placed through a stab wound‡ 
into the organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or 
tissue in the organ/space. 
3. An abscess or other evidence of infection involving the organ/space 
that is found on direct examination, during reoperation, or by histopathologic 
or radiologic examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
National Nosocomial Infection Surveillance definition: a nonhuman-derived 
implantable foreign body (e.g., prosthetic heart valve, nonhuman vascular graft, 
mechanical heart, or hip prosthesis) that is permanently placed in a patient 
during surgery. If the area around a stab wound becomes infected, it is not an 
SSI. It is considered a skin or soft tissue infection, depending on its depth. 
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CDC Classification of Surgical Wounds 
Classification Criteria 
Clean Elective, not emergency, non-traumatic, 
primarily closed; no acute inflammation; no break 
in technique; respiratory, gastrointestinal, biliary 
and genitourinary tracts not entered 
Clean-contaminated Urgent or emergency case that is otherwise clean; 
elective opening of respiratory, gastrointestinal, 
biliary or genitourinary tract with minimal spillage 
(e.g. appendectomy) not encountering infected 
urine or bile; minor technique break. 
Contaminated Non-purulent inflammation; gross spillage from 
gastrointestinal tract; entry into biliary or 
genitourinary tract in the presence of infected bile 
or urine; major break in technique; penetrating 
trauma <4 hours old; chronic open wounds to be 
grafted or covered 
Dirty Purulent inflammation (e.g. abscess); 
preoperative perforation of respiratory, 
gastrointestinal, biliary or genitourinary tract; 
penetrating trauma >4 hours old 
 
Antibiotic prophylaxis 
Inoculation of the surgical site occurs during surgery, either inward from 
the skin or outward from the internal organ being operated on, hence the 
rationale for skin preparation with antiseptics, and prophylactic administration 
of antibiotics. The microbiology of SSI depends on the type of operation being 
performed, but most SSIs are caused by skin-derived gram-positive cocci, 
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including Staphylococcus aureus, coagulase-negative staphylococci (usually 
Staphylococcus epidermidis), and Enterococcus spp. With surgery of the head 
and neck, (when pharyngoesophageal structures are entered) or intestinal 
surgery, enteric aerobic (e.g. Escherichia coli) and anaerobic (e.g. Bacteroides 
fragilis) bacteria may cause SSIs. However, it is only the surgical incision that 
is afforded protection, and antibiotics are not a panacea. If not administered 
properly, antibiotic prophylaxis will not be effective and may be harmful. 
Antibiotic prophylaxis is indicated clearly for most clean-contaminated and 
contaminated (or potentially contaminated) operations. Antibiotic prophylaxis 
of clean surgery is controversial. Where bone is incised (e.g. craniotomy or 
sternotomy) or a prosthesis is inserted, antibiotic prophylaxis is generally 
indicated. The choice of antibiotic should be guided by four principles: safety, 
narrow spectrum coverage of relevant pathogens, no general use for treatment 
of infection, and short-duration administration (ideally, a single dose given one 
to two hours before surgery; certainly for no more than 24 hours (48 hours for 
cardiac surgery). A first-generation cephalosporin is the preferred agent for 
most patients, with clindamycin preferred for patients with a history of 
anaphylaxis to penicillin. Unfortunately, recent US data indicate that 
prophylactic antibiotics are administered to only 56% of patients within one 
hour of surgery. Disconcertingly, antimicrobial prophylaxis was discontinued 
within 24 hours of surgery only 41% of the time. Prolongation of antibiotic 
prophylaxis beyond 24 hours not only provides no benefit, but can be 
associated with complications, including Clostridium difficile-associated 
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colitis, nosocomial infections other than SSI, and the emergence of multi-drug-
resistant pathogens. Both pneumonia and catheter-related infections have been 
associated with prolonged antibiotic prophylaxis, as has the emergence of SSI 
caused by methicillin-resistant  Staphylococcus aureus 
Timing of antibiotic prophylaxis: 
A prospective observational study using logistic regression to analyse 
data collected from patients undergoing elective clean or clean-contaminated 
surgery at a teaching hospital examined the timing of antibiotic prophylaxis 
administration as a risk factor for SSI.(60) 
Patients were assigned to groups according to the time between their 
first dose of antibiotic prophylaxis and the initial surgical incision. The early 
group received prophylaxis 2–24 hours pre-incision, the preoperative group 0–
2 hours pre-incision, the perioperative group up to 3 hours post-incision and the 
postoperative group received antibiotic prophylaxis 3–24 hours post-incision. 
Forty-four of 2847 included patients (1.5%) developed SSI. Logistic regression 
demonstrated that there were statistically significantly more infections in the 
early and postoperative groups compared with the perioperative group .Results 
were further stratified according to the hour that prophylaxis was administered 
in relation to the time of surgery – the early group were excluded from this 
analysis. The lowest SSI rate occurred in patients receiving antibiotic 
prophylaxis 0–2 hours prior to surgery. A statistically significant trend was 
observed toward higher rates of infection with each successive hour. That 
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antibiotic administration was delayed after the surgical incision (z score = 2.00, 
P <0.05 Wilcoxon test). 
Evidence statement – timing of antibiotic prophylaxis 
There is evidence that administration of antibiotic prophylaxis up to 2 
hours preoperatively is associated with the lowest rates of infection in clean 
and clean contaminated surgery. 
Recommendations on antibiotic prophylaxis 
Give antibiotic prophylaxis to patients before: 
• clean surgery involving the placement of a prosthesis or implant 
• clean-contaminated surgery 
• contaminated surgery. 
Do not use antibiotic prophylaxis routinely for clean non-prosthetic 
uncomplicated surgery. Use the local antibiotic formulary and always consider 
potential adverse effects when choosing specific antibiotics for prophylaxis. 
Consider giving a single dose of antibiotic prophylaxis intravenously on 
starting anaesthesia. However, give prophylaxis earlier for operations in which 
a tourniquet is used. Before giving antibiotic prophylaxis, consider the timing 
and pharmacokinetics (for example, the serum half-life) and necessary infusion 
time of the antibiotic. Give a repeat dose of antibiotic prophylaxis when the 
operation is longer than the half-life of the antibiotic given. Give antibiotic 
treatment (in addition to prophylaxis) to patients having surgery on a dirty or 
infected wound. Inform patients before the operation, whenever possible, if 
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they will need antibiotic prophylaxis, and afterwards if they have been given 
antibiotics during their operation. 
EMBRYOLOGY 
Liver arises in the fourth week as a diverticulum from the ventral 
surface of the duodenal foregut, close to its junction with the midgut where the 
later is continuous with the yolk stalk this diverticulum, lined with endoderm, 
grows vertically and cranially into the septum transversum, its tip diverges into 
two solid hepatic buds of cells, the further right and left lobes of liver, the buds 
develops into epithelial trabeculae or sheet (so called hepatic cylinders), which 
branch and anastamose to form a closed meshwork. The interval of meshwork 
become filled with blood sinusoids and on section the organ has the appearance 
of vascular sponge, The original diverticulum from the duodenum forms the 
bile duct and from its distal part the cystic duct and gall bladder arise as an 
outgrowth, solid at first but latercanalized.  
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ANATOMY 
The gallbladder is a pear-shaped sac lying on the visceral surface of the 
right lobe of the liver in a fossa between the right and quadrate lobes. 
It has: 
• a rounded end (fundus of gallbladder), which may project 
from the inferior border of theliver, 
• a major part in the fossa (body of gallbladder), which may be 
against the transverse colon and the superior part of 
theduodenum; 
• anarrowpart(neckofgallbladder)withmucosalfoldsformingthespiralfo
ld. 
 
 
 
Figure 2: Anatomy of the gall bladder 
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The gallbladder varies from 7 to 10 cm in length and from 2.5 to 3.5 cm 
in width. A moderately distended gallbladder has a capacity of 50 to 60 ml of 
bile.  
Hartmann's pouch is an asymmetrical bulge of the infundibulum that lies 
close to the gallbladder's neck. It is a common site for a gallstone to lodge. The 
neck points in a cephalad and dorsal direction to join the cysticduct.  
The gallbladder wall consists of five layers. The innermost layer is the 
epithelium, and the other layers are the lamina propria, smooth muscle, 
perimuscular subserosal connective tissue, and serosa. The gallbladder has no 
muscularis mucosa or submucosa. The lamina propria contains nerve fibers, 
vessels, lymphatics, elastic fibers, loose connective tissue, and occasional mast 
cells and macrophages. The muscle layer is a loose arrangement of circular, 
longitudinal, and oblique fibers without well-developed layers. 
Rokitansky-Aschoff sinuses are invaginations of epithelium into the 
lamina propria, muscle, and subserosal connective tissue. The ducts of Luschka 
are tiny bile ducts found around the muscle layer on the hepatic side of the 
gallbladder. [12] 
Anatomy of biliary tract 
The right and left hepatic ducts emerge from the liver and unite in the 
porta hepatis to form the common hepatic duct. The cystic duct arises from the 
gallbladder and joins the common hepatic duct to form the common bile duct. 
The length of the cystic duct is variable, averaging between 2 and 4 cm. The 
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cystic duct contains a variable number of mucosal folds, similar to those found 
in the neck of the gallbladder. Although referred to as valves of Heister, these 
spiral folds do not have a valvular function. 
The common bile duct runs between the layers of the lesser omentum, 
lying anterior to the portal vein and to the right of the hepatic artery. Passing 
behind the  first part of the duodenum in a groove on the back of the head of the 
pancreas, it enters the second part of the duodenum. The duct runs obliquely 
through the posterior-medial wall, usually joining the main pancreatic duct to 
form the Ampulla of Vater (1720). The ampulla makes the mucous membrane 
bulge inwards to form an eminence: the duodenal papilla. In about 10-15% of 
subjects the bile and pancreatic ducts open separately into theduodenum. 
 
 
Figure 3: Anatomy of the biliary tree 
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The dimensions of the common bile duct depend on the technique used. 
At operation it is about 0.5-1.5 cm in diameter. Using endoscopic 
cholangiography, it is usually less than 11 mm and values greater than 18 mm 
are pathological. By ultrasound the values are less, the common bile duct being 
2-5 mm and values greater than this are abnormal.[13] 
The duodenal portion of the common bile duct is surrounded by a 
thickening of both longitudinal and circular muscle fibres derived from the 
intestine. This is called the sphincter of Oddi. [14] 
 
Figure 4: Anatomy of the sphincter of Oddi 
Calot’s Triangle 
In 1891, Calot described a triangular anatomic region formed by the 
common hepatic duct medially, the cystic duct laterally, and the cystic artery 
superiorly. Calot's triangle is considered by most to comprise the triangular 
area with an upper boundary formed by the inferior margin of the right lobe of 
the liver, rather than the cystic artery. During performance of a 
cholecystectomy, clear visualization of the hepatocystic triangle is essential 
with accurate identification of al
Blood supply 
The gallbladder receives blood from the 
hepatic artery is large, tortuous and variable in its anatomical relationships. 
Smaller blood vessels
venous drainage is into the 
Figure 6: Arterial blood supply of the gall bladder
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l structures within this triangle.
Figure 5: Calot’s triangle 
cystic artery. This branch of the 
 enter from the liver through the gallbladder fossa. The 
cystic vein and hence into the portal venous system.
 
[12] 
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The arterial blood supply to the supra-duodenal bile duct is generally by 
two main (axial) vessels, which run beside the bile duct in the 3’o’ clock and 
9’o’ clock position. [15] These are supplied predominantly by the retro-duodenal 
artery from below, and the right hepatic artery from above, although many 
other vessels contribute. This pattern of arterial supply would explain why 
vascular damage results in bile duct stricturing. 
 
Figure 7 : Arterial blood supply of the extrahepatic biliary tree 
 
Lymphatics 
There are many lymphatic vessels in the sub mucous and sub peritoneal 
layers. These drain through the cystic gland at the neck of the gallbladder to 
glands along the common bile duct, where they anastomose with lymphatic 
from the head of the pancreas. 
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Nerve supply 
The gallbladder and bile ducts are liberally supplied with nerves, from 
both the parasympathetic and sympathetic system. [16] 
 
Figure 8: Nerve supply to the extrahepatic bile tree. 
Laparoscopic anatomy [17] 
The advent and popularity of LC has led to a new look and insights into 
the biliary anatomy especially of the Calot’s triangle area and the term 
“laparoscopic anatomy” has actually found a place even in anatomy texts. 
The different anatomical ‘laparoscopic view’ of the area around the 
gallbladder especially the Calot’s triangle does contribute to misidentification 
of strictures. The method of retraction during the laparoscopic procedure tends 
to distort the Calot’s triangle by actually flattening it rather than opening it out. 
Also the reluctance to (or difficulty) performing a fundus first cholecystectomy 
during the laparoscopic procedure as approved to open procedure also 
contributes to the some lack of exposure of the Calot’striangle. 
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Finally the ‘posterior’ or ‘reverse’ dissection of the Calot’s triangle, 
which is popular during LC, again gives a different view of the area and since 
the gallbladder is view of the area and since gallbladder is flipped over during 
the method may lead to further anatomical distortion. The Rouviere’s sulcus is 
fissure on the liver between the right lobe and caudate process and is clearly 
seen during a LC during a posterior dissection in majority of patients. 
It corresponds to the level of the porta hepatic where the right pedicle 
enters the liver. It has been recommended that all dissection be kept to a level 
above  (or anterior) to this sulcus to avoid injury to the bileduct. 
Also, this being an “extrabiliary” reference point it does not get affected 
by distortion due to pathology. Similarly, a clear delineation of the junction of 
cystic duct with the gallbladder along with the demonstration of a space 
between the gallbladder and the liver clear of any structure other than the 
cystic artery (safety window or critical window) is also recommended as an 
essential step to prevent bile duct injury. 
 
Figure 9: Rouviere’s sulcus 
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GALLSTONES 
INCIDENCE: 
Gallstones are the most common biliary pathology. The incidence of 
biliary calculous disease varies widely throughout the world. By the age of 75, 
about 35% of women and 20% of men would have developed gallstones. The 
incidence of gallstone disease in Asia is considerable and constitutes a problem 
of enormous magnitude. The incidence of cholesterol gallstones is increasing 
in Asia for the reasons that may be related to environmental and dietary 
considerations. 
Most patients with gallstones are asymptomatic and only about 10% 
will have developed symptoms five years after discovery. In a functioning gall 
bladder, most of the gall stones are cholesterol stones. Gall stone disease is a 
relatively common problem in our country particularly in North India. It is 
estimated that more than sixty percent of these patients have cholesterol stones. 
Recent studies from south India have highlighted pigment and mixed variety of 
gall stones to be more common (> 90 %) in contrast to cholesterol stones. 
 
RISK FACTOR ASSOCIATED WITH GALLSTONE FORMATION:[20] 
1.Cholesterolstones 
        Age > 40years 
        i.Estrogens 
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a. Female sex (2-3 times the risk inmen) 
b. Pregnancy (risk increases with number ofpregnancies) 
c. Estrogen containingOCPs. 
ii. Genetic or ethnicvariation 
iii. High fat, low fiberdiet 
iv. Obesity 
v. Hyperlipidaemia 
vi. Bile salt loss ( Ileal disease or resection; Crohn’s disease) 
vii. Cysticfibrosis 
viii. Anti-hyperlipidaemic drugs ( Clofibrate ) 
ix. Impaired gall bladderemptying 
a. Truncalvagotomy 
b. Type-1diabetes 
c. Octreotide 
d. Total parenteralnutrition 
e. Starvation or rapid voluntary weightloss 
2. Pigmentstones 
i. Haemolyticdisease 
ii. Biliarystasis 
iii. Biliaryinfection 
In India, there is a dual pattern of prevalence. Some studies have shown 
that North Indians are more prone to cholelithiasis than South Indians. The 
nature of the disease is also different in North India and South India. In North 
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India, Cholesterol stones form the majority of gallstones. In contrast to this, 
pigment stones are more frequent in South India. 
 
CLINICAL FEATURES: 
Clinical Presentation of Gallstones: 
1. Asymptomatic. 
2. Biliarycolic. 
i. Right subcostal or epigastric pain radiating to back or lower pole ofscapula 
lasting for 20 minutes to 6hours. 
ii. Associated with vomiting, brought on by (any)food. 
iii. May disturb sleep. 
3. Flatulent dyspepsia. 
4. Acute Cholecystitis - Calculous (as opposed to Acalculous)/ Empyema 
gallbladder/ Gangrenous Gallbladder. 
i. Severe pain and tenderness in right subcostal region - Murphy sign - pain on 
palpation of the right upper quadrant when the patient inhales. 
ii. Fever and leucocytosis. 
5. Chronic calculous Cholecystitis - repeated episodes of right hypochondrial 
pain with/without fever and vomiting. 
6. Cholangitis - Fever with chills/rigors, transient jaundice, upper 
abdominal pain, vomiting - Charcot triad (right upper quadrant pain, fever, and 
jaundice) 
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7. Mucocele - Heaviness in upper abdomen; palpable lump. 
8. Choledocholithiasis with extra-hepatic cholestasis. 
9. Biliary pancreatitis. 
10. Gallstone ileus. 
11. Gallbladder perforation. 
12. Gallbladder carcinoma. 
 
 
 
Figure 16: Schematic depiction of the natural history  
and complications of gallstones. 
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The percentages indicate the approximate frequencies of complications 
that occur in untreated patients, based on natural history data. The most 
frequent outcome is for the patient with a stone to remain asymptomatic 
throughout life (1). Biliary pain (2),  acute cholecystitis (3), cholangitis (5), and 
pancreatitis (5) are the most common complications. Mirizzi's syndrome (4), 
cholecystoenteric fistula (6), Bouveret's syndrome (6), and gallbladder cancer 
(7) are relatively rare.[22] 
INVESTIGATIONS: 
A variety of diagnostic modalities are available for the patient with 
suspected disease of the gallbladder and the bile ducts. In 1924, the diagnosis 
of gallstones was improved significantly by the introduction of oral 
cholecystography by Graham and Cole. For decades it was the mainstay of 
investigation for gallstones. In the 1950’s biliary scintigraphy was developed, 
and later trans hepatic and endoscopic retrograde cholangiography, allowing 
imaging of the biliary tract. Later ultrasonography, computed tomography 
(CT), and magnetic resonance imaging (MRI), vastly improved the ability to 
image the biliary tract.[24] 
1. Blood investigations. 
2. Plain X-ray abdomen. 
3. Oral Cholecystography. 
4. Cholangiography. 
4. Ultrasonography(USG). 
5. Computed Tomography(CT). 
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6. Magnetic Resonance Cholangio Pancreatography(MRCP). 
7. Endoscopic Retrograde Cholangio Pancreatography(ERCP). 
8. Hepato biliary Scintigraphy. 
Blood investigations: 
Nearly 50% of patients with symptomatic gallstone disease will have 
abnormal transaminases. An elevated white blood cell count alerts the clinician 
to the possibility of acute cholecystitis, a condition requiring more urgent 
treatment. Serum lipase and amylase levels are helpful in cases of diagnostic  
uncertainty or suspected  concurrent pancreatitis. Coagulation parameter 
results measured by prothrombin (PT) and activated  partial  thromboplastin  
time  (aPTT)  might  be  abnormal  in  the severely jaundiced patient due to 
dysfunction in vitamin K absorption. 
Plain X-ray abdomen: 
 PlainabdominalX-rayisapreliminaryscreeningtestsinceonlyabout10%of 
gallstones  are  radio-opaque.  A  porcelain  gallbladder  (heavily  calcified)  
should be removed surgically because of increased risk of gallbladder cancer. 
More the less, gallstones are so common that they are the most frequent cause 
of discrete right upper quadrant calcifications. The smaller numbers of 
calcified gallstones that will be seen on plain films are indicative that the 
majority of stones are cholesterol based and contain little calcium. 
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Figure 17A: Plain radiograph showing         Figure 17B: Porcelain gall bladder  
radio-opaque stones in the gallbladder 
Oral Cholecystography: 
 In 1924, Graham and Cole introduced the concept of oral 
cholecystography. For many years, this test was considered the main stay and 
gold standard for the diagnosis of gall stone disease. It was based on two 
physiologic principles; halogenated dyes are excreted in bile and the 
gallbladder is capable of concentrating bile 8 to 10 fold. In a normally 
functioning gall bladder, dye is concentrated as are sult or the absorptive 
function of the gallbladder and it will appear opacified. The presence of 
gallstones is suggested by the appearance of filling defects in an otherwise 
opacified gallbladder or by non-visualization. The latter is indicative of 
reduced absorption, which is  consistent   with  chronic  cholecystitis.   The  
accuracy  of  oral   cholecystography is between 95 - 99%. 
32 
    
 
 
Normal Oral cholecystogram                        Cholecystogram showing multiple  
  gallstones 
Figure 18: Oral cholecystography 
Cholangiography: 
Routine cholangiography during laparoscopic cholecystectomy has been 
advocated to confirm anatomy and thus prevent ductal injury. 
An intra operative  cholangiography  provides  a  “road  map”  of  entire  
biliary  system  and  aids  in the dissection of the function between cystic and  
common bileducts which is of great value in cases where anatomic land marks 
are not clearly identified or where variation to the normal ductal anatomy are 
present. 
  
Figure 19: Normal intraoperative cholangiogram. Contrast can be seen clearly 
entering the cystic duct, flowing into the common bile duct and up into the 
Ultrasonography: 
An ultrasound is the initial investigation of any patient suspected o
disease of the biliary
patient to radiation, and can be performed.
Ultrasonography can detect stones larger than 1 to 2 mm in diameter; 
can rule out alternative causes of right
abscess; and can suggest the presence of common
bile duct dilatation. 
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 upper quadrant pain, 
 bile duct stones by showing 
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Findings include gallstones or sludge and one or more of the following 
conditions: 
1. Gallbladder wall thickening (>2-4 mm) - False positive wall thickening 
found in acute hepatitis, portal hypertension, hypo albuminemia, ascites, 
congestive cardiac failure and carcinoma.[26] 
2. Gallbladder distention (diameter >4 cm, length >10 cm). 
3. Pericholecystic fluid from perforation or exudates. 
4. Air in the gallbladder wall (indicating gangrenous cholecystitis or 
emphysematous cholecystitis). 
The diagnosis of stones by ultrasound examination is highly specific if 
the operator sees a moveable echogenic spot that produces a shadow. Stones 
are acoustically dense and reflect the ultrasound waves back to the ultrasonic 
transducer. Because stones block the passage of sound waves to the region 
behind them, they also produce an acoustic shadow. Ultrasound examination 
sludge as a lower, liquid phase with tiny echoes that do not produce shadow. 
  
Its disadvantage is that it is operator
be underestimated. 
Figure 20(A): Typical ultrasonographic appearance of cholelithiasis. A 
gallstone is present within the lumen of the gallbladder (GB), casting an 
acoustic shadow. 
Figure 20(B): Cholelithiasis in the setting of acute cholecystitis. 
Multiple gallstones can be seen within the gallbladder lumen with associated 
acoustic shadowing. In addition, the gallbladder wall is thickened 
(arrowheads). 
Computed Tomography:
Computed tomography
cholelithiasis. Obvious
although they may be
Although this test is 
does  not  provide important
location  of  biliary dilatation and
pancreas. In general,
ultrasonography  when  the  concern  is  extrahepatic
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-dependent, number of stones may 
 
 scan are not a first-line test for
 gallstones frequently are missed 
 seen as incidental finding, if they are densely
not  particularly  sensitive  for  identifying  gallstones,  it  
 information regarding the nature,  extent,  and  the 
 masses in and around the biliary
 this test provides more useful  information  than  
 obstruction  owing  to  
 
 the diagnosis of 
by routine CT, 
 calcified. 
 tract and for 
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cause  other  than  choldocholithiasis.  Limiting factors for CT scanning 
include patient exposure to ionizing radiation and cost. 
 
Normal CT Scan of gall bladder 
 
CT image demonstrates a large gallstone (arrow) in the gallbladder. 
Figure 21: CT image of gall bladder 
Magnetic Resonance Cholangio Pancreatography (MRCP): 
          Recently, MR cholangio-pancreatography (MRCP) has emerged as an 
alternative to endoscopic retrograde cholangiography, averting the need for 
invasive diagnostic testing  in  patients  who  are  unlikely  to  require  any  
therapeutic  intervention. With MRCP, no contrast material is administered,  
but  native high signal intensity of fluid on
imaging of the biliary
MRI cholangiography for detecting choledocholithiasis is over 90 %. 
 
Endoscopic Retrograde Cholangio Pancreatography (ERCP): 
Using a side
cannulated  and a cholangiogram  performed  using  fluoroscopy.  The  
procedure  requires intravenous sedation
endoscopic retrograde
the ampullary region
possibility of therapeutic
uncomplicated gallstone
particular when associated with obstructive jaundice, cholangitis, or
pancreatitis, ERCP is
Once the endoscopic  cholangiogram  has  sh
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 T2-weighted
 tree. A preliminary study has found that the sensitivity of 
Figure 22: Normal MRCP image 
-viewing endoscope, the common bile duct  can be 
 for the patient. The
 cholangiography (ERC) include direct
 and direct access to the  distal common bile
 intervention. The test is rarely
 disease, but for stones in the common
 the diagnostic and often therapeutic procedure
own  ductal  stones,  
 images permits 
[27]
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 advantages of 
 visualization of 
 duct, with the 
 needed for 
 bile duct, in 
 gall stone 
 of  choice. 
sphincterotomy and 
duct cleared of stones.
 
 
 
Figure 23: Endoscopic Retrograde cholangiopancreatography demonstrating 
                stone obstructing the common bile duct (arrow).
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stone extraction can be performed, and the common bile 
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Hepatobiliary Scintigraphy: 
Nuclear cholescintigraphy permits the rapid assessment of gallbladder function 
in a patient with suspected acute cholecystitis.[29] The short-lived isotope 
technetium- 99m is bound to one of several iminodiacetic acids (such as 
hydoxyiminodiacetic acid- HIDA or diisopropyl iminodiacetic acid - DISIDA) 
that are excreted into the bile ducts. Gamma rays emitted by the tracer are used 
to make an image of the bile ducts and gallbladder. Failure of the tracer to 
enter the gallbladder suggests obstruction of the neck of the gallbladder, as 
occurs in acute cholecystitis. 
HIDA scan is the most sensitive and specific test for acute cholecystitis - 
calculus and acalculous. A poorly contracting gallbladder (biliary dyskinesia) 
might cause the patient’s symptoms, and HIDA scan helps in making the 
diagnosis. Cholescintigraphy can provide functional information about 
gallbladder contraction and can detect total obstruction of the bile duct, but it 
cannot provide anatomical information and cannot identify gallstones. 
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Figure 24: Cholescintigraphy demonstrating an obstructed cystic duct 
characteristic of acute cholecystitis.  
The failure of the gallbladder to be visualized as a hot spot within 30 to 60 
minutes constitutes a positive result and implies obstruction of the cystic duct. 
. 
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MANAGEMENT OF GALLSTONE DISEASES 
NON-OPERATIVE MANAGEMENT [30] 
Medical treatment of gallstone disease was first proposed by Schiff in 
Italy in 1873. Dabney of Virginia first reported the effective treatment of 
gallstones with bile acids in 1876.Despite these initial reports, the use of 
medical dissolution treatment did not gain acceptance until large clinical series 
were reported in the 1970s. 
Contact dissolution of gallstones with solvents and percutaneous 
cholecystolithotomy techniques also have been reported, but these modalities 
have not proved superior to oral dissolution, shock-wave lithotripsy, or 
laparoscopic cholecystectomy and have been abandoned. The mainstay of 
current non-surgical treatment of gallstone disease is oral dissolution with 
ursodeoxycholic acid, with or without extracorporeal shock-wave lithotripsy. 
 
1. DissolutionTherapy 
The rationale for oral dissolution therapy is the reversal of the condition 
that led to formation of cholesterol gallstones, namely, the supersaturation of 
bile with cholesterol. Cholesterol stones dissolve if the surrounding medium is 
capable of solubilizing the cholesterol in the stones. Both chenodeoxycholic 
acid and ursodeoxycholic acid dissolve gallstones by decreasing biliary 
cholesterol secretion and desaturating bile. These agents encourage the 
removal of cholesterol from stones via micellar solubilization, formation of a 
liquid crystalline phase, or both. 
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Chenodeoxycholic acid was the first bile acid used for gallstone dissolution 
but has been abandoned because of side effects, including diarrhea and 
increased serum aminotransferase and cholesterol levels. Ursodeoxycholic acid 
is well tolerated and is currently used in oral dissolution regimens. Oral 
dissolution therapy should be considered for patients with uncomplicated 
gallstone disease, including those with mild, infrequent biliary pain. In 
addition, the gallbladder must function and the cystic duct must be patent to 
allow unsaturated bile and stones to clear from the gallbladder. Oral dissolution 
therapy works only on cholesterolstones. 
 
Table 3: Selection Criteria for Oral Bile Acid DissolutionTherapy 
 
Stage disease Of 
gallstone 
• Symptomatic (biliary pain) without complications 
 
 
 
Gallbladder function 
• Opacification of gallbladder on oral cholecystography 
(patent cystic duct) 
• Normal result of stimulated cholescintigraphy (normal 
GBemptying) 
• Normal result of functional ultrasonography(normal 
gallbladder emptying after a test meal) 
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Stone characteristics 
• Radiolucent on radiography 
• Isodense or hypodense to bile and absence  of 
calcification on CT scan 
• Diameter <6 mm (optimal) or 6-10 
mm(acceptable) 
 
 
Ursodeoxycholic acid (ursodiol) is the preferred drug for oral dissolution 
treatment. It is taken in a dose of 10 to 15 mg/kg of body weight per day. 
Nighttime dosing is more effective and is associated with better patient 
compliance than mealtime dosing. Treatment should continue until stone 
dissolution is documented by two consecutive negative ultrasonograms at least 
one month apart. 
2. Extracorporeal shock wave lithotripsy(ESWL) 
The application of extra corporeal shock-wave lithotripsy to the treatment 
of gallstones was first applied to patients by Sauerbruch in 1985.The rationale 
for shock- wave lithotripsy is to diminish the surface-to-volume ratio of a 
stone, thereby increasing the efficacy of oral dissolution and decreasing stone 
size to allow small stones and debris to pass directly from the gallbladder into 
the intestine without causing symptoms. The technique involves the delivery of 
focused high-pressure sound waves to gallstones. Passage of the shock wave 
through the anterior and posterior walls of the stone liberates compressive and 
tensile forces and causes cavitation at the anterior surface of the stone, thereby 
leading to stone fragmentation. Factors that influence fragmentation include 
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the size, microcrystalline structure, and architecture of the stone. 
Because shock-wave lithotripsy is usually combined with oral dissolution 
therapy, patient selection criteria for shock-wave lithotripsy are similar to those 
for oral dissolution treatment. Gallbladder function and cystic duct patency are 
required and are demonstrated by oral cholecystography, functional 
ultrasonography, or stimulated cholescintigraphy. Lithotripsy should be 
considered only for patients with mild, uncomplicated biliary pain. Pregnant 
patients and patients on anticoagulants should not undergo lithotripsy. Because 
only cholesterol stones are reliably cleared by the addition of oral dissolution 
therapy, stones should have radiographic features, such as radiolucency, 
suggestive of cholesterol stones. 
Side effects of lithotripsy include petechiae of the skin at the site of 
shock-wave delivery (8%), hematuria (4%), and liver hematomas (<1%). No 
long-term liver biochemical abnormalities have been noted. Biliary pain 
develops in approximately one third of patients; cystic duct obstruction 
develops in 5%; and complications of stone passage, such as biliary 
pancreatitis, develop in less than 2%. 
Lithotripsy is more cost-effective in the elderly than in the young and 
less cost- effective in patients with multiple stones than in those with a single 
stone. 
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OPERATIVE MANAGEMENT 
Cholecystectomy is one of the most common major abdominal operations. 
Cholecystectomy can be performed by open and laparoscopic methods. 
The indications for cholecystectomy are the same for both techniques.[31] 
These include: 
1. Symptomatic gallstones causing 
i. Repeated episodes of biliarypain 
ii. Mucocele of thegallbladder 
iii. Choledocholithiasis with extra-hepaticcholestasis 
iv. Biliarypancreatitis 
v. Gallstoneileus 
 
2. Cholecystitis and its complications - acute calculous / acalculous cholecystitis, 
chronic cholecystitis, empyema gallbladder, gangrenous cholecystitis, 
gallbladder perforation. 
3. Asymptomatic cholelithiasis: Laparoscopic cholecystectomy is indicated in 
asymptomatic cholelithiasis in certain selectiveindications: 
i. Patients undergoing bariatricsurgery. 
ii. Diabetics. 
iii. Renaltransplantation. 
iv. Children. 
v. Those with hemolytic diseases with multiple pigmentstones. 
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4. ‘Gallstone dyspepsia’: Patients with ‘classic’ biliary pain without evidence of 
gallstone may benefit from cholecystectomy. Biliary dyskinesia can be 
detected by objective measurements of changes in gallbladder 
volumes(ejection fraction <35%) or reproduction of the pain on consumption 
of fatty meal or cholecystokinin infusion. These patients may benefit from 
surgery. However, one should warn the patient that 20-30% of patients 
operated for dyspepsia have a persistence of symptoms. 
 
5. Gallbladderpolyps. 
Traditionally, open cholecystectomy has been the gold standard for all 
patients with symptomatic gallstonedisease.[32] 
LAPAROSCOPIC CHOLECYCTECTOMY [39,40] 
Indications: 
The indications for laparoscopic cholecystectomy remain the same as for 
open cholecystectomy. 
 
Contra-indications: 
1. Patients unfit for general anaesthesia. 
2. Significant portal hypertension. 
3. Uncorrectable coagulopathy. 
4. Patients with proven or suspected gallbladder cancer. 
5. Surgeon inexperienced in laparoscopic surgery. 
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Pre-operative Work-up: 
1. Routine blood tests, including liver function tests. 
2. Ultrasonography. 
3. Upper GI endoscopy - to identify patients with acid peptic disorders or hiatus 
hernia 
4. DVT prophylaxis in high risk patients. 
Drawbacks of laparoscopic cholecystectomy: 
1. The incidence of bile duct injuries is more as compared to open 
cholecystectomy. 
2. The operating time required for laparoscopy cholecystectomy is more as 
compared to open method. 
Advantages: 
1. Laparoscopic cholecystectomy is associated with a lower risk of surgical site 
infection than open method, even after adjustment for other risk factors. 
2. Post operative pulmonary function was impaired less after laparoscopic than 
after open cholecystectomies. 
3. Postoperative pain is less. 
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LAPARASCOPY CHOLECYSTECTOMY 
Anaesthesia: 
 
 
General anaesthesia is the preferred anaesthetic method for patients 
undergoing most therapeutic laparoscopic surgical procedures. Two advantages 
of general anaesthesia as compared to other types of anaesthesia are two folds: 
1.It allows for complete control of the patient’s ventilation, which might 
otherwise be compromised by systemic absorption of CO2 and increased 
diaphragmatic pressure from the pneumoperitoneum. 
2.It enables complete relaxation of the abdominal wall muscles necessary for 
adequately maintaining pneumoperitoneum. 
Patient Position and Room Set-up: 
 
 
North American Approach: The patient is kept supine in anti-
Trendelenburg position (150 head up tilt) with left lateral tilt (15-200). This 
ensures that the bowel and omentum falls down and medially, away from the 
operative site. The operating surgeon and camera surgeon stand on the left of 
the patient while the assistant surgeon stands on the right of the patient. The 
monitor is kept beyond the right shoulder of the patient facing the operating 
surgeon. An additional monitor may be kept beyond the left shoulder of the 
patient for the assistant surgeon. 
The camera port (10 mm) is placed in the midline, usually through the 
umbilicus. The remaining trocars are: 10 mm in the epigastric region, 5 mm in 
the mid-clavicular line sub-costallv and 5 mm in the anterior axillary line 
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subcostally. 
 
French/European Approach: The patient is in semi-lithotomy anti-
Trendelenburg position with the legs in Allen stirrups such that the thighs are 
almost parallel to the ground to avoid interference with the manipulations of 
the operating instruments. The operating surgeon stands between the legs of 
the patient with the camera surgeon on the right of the patient and the assistant 
on the left of the patient. 
The camera port placement remains the same as in the North American 
approach. Epigastric port (5 mm) is placed to allow retraction by the assistant. 
The right hand working port (10 mm) is placed in the left hypochondrium or in 
the midline between the camera port and the epigastric port. The left hand 
working port (5 mm) is placed in the right hypochondrium. 
 
 
 
 
Figure 42: Shown are the positions of the surgeon, the camera operator, and the 
assistant in the OR according to (a) North American positioning and (b) 
European positioning 
50 
 
 
 
 
 
Figure 43: Differences between typical North American practice (a) and typical 
European practice (b) with respect to the placement of the trocars and the 
instruments inserted through each port. 
 
Technique: 
 
 
1. Pneumoperitoneum and portplacement: 
 
 
Patient is positioned in supine with 10 to 20 degree head down to displace 
the intestines cranially. In the absence of operative scar, periumbilical site 
(thinnest site) is the most preferred site for Veress needle insertion. Depending 
on the shape of umbilicus, either a transverse or vertical stab is made with a 
number 15 or 11 knife. The shaft of the Veress needle should be held by the 
right hand, keeping the distal length of the needle tip just adequate to traverse 
the entire thickness of the abdomen wall. While inserting the needle, the little 
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finger and ulnar border of the right palm is propped against the abdomen. 
 
The abdominal wall is lifted midway between the pubic symphysis and 
umbilicus by the left hand .The Veress needle is inserted either at a 45 degree 
caudal angle to the abdominal wall (in the asthenic or minimally obese patient) 
or perpendicular (in the markedly obese patients). 
 
Figure 44: Veress needle insertion 
 
Several maneuvers should be carried out to confirm the free intraperitoneal 
position of the needle. First, the needle is aspirated and irrigated to demonstrate 
the absence of return of blood or bowel contents and a free flow of fluid. 
Second, a saline drop test is performed in which the needle is filled with saline 
and fluid is demonstrated to flow freely by gravity into the peritoneal cavity as 
negative pressure is generated by lifting the abdominal wall. Finally, the needle 
is moved back and forth, which indicates that the tip is free within the 
peritoneal cavity. 
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The needle is connected to the insufflator and CO2 is instilled at a rate of 1 
L/min. The opening pressure recorded on the insufflator should be < 10 
mmHg. Initial pressures of 10 mmHg or higher may indicate the placement of 
the needle in the pre- peritoneal or other closed space. Upon insufflating 
approximately 1L of CO2, increased tympany in all four quadrants of the 
abdomen is confirmed, and the flow rate may be increased. Although high flow 
insufflators are designed to deliver flow rates of up to 8 to 10 L/min, the 
maximum flow rate through the small caliber Veress needle is approximately 
2.5 L/min. Once the intra-abdominal pressure has reached 15 mmHg, generally 
requiring 3 to 6 L of CO2, the Veress needle is removed, and the trocar is 
inserted through the same site. 
 
The trocar is grasped firmly in the palm of one hand and inserted using 
gently  firm pressure while elevating the abdominal wall with the other hand or 
with towel clips. Once the port is in, the inner trocar is removed, leaving the 
outer cannula and sheath in place. Return of CO2 gas is confirmed by opening 
either the stopcock or flapper valve on the port and then connecting the 
insufflation line to the sheath. The video telescope is inserted and a general 
inspection of the peritoneal cavity, including underlying viscera and 
retroperitoneum, is carried out to assess for visceral injury. 
 
The patient is placed in the anti-Trendelenburg position so that the 
intestines and viscera will fall downwards and to the left. The gallbladder is 
inspected. The remaining three trocars are inserted under vision. 
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The epigastric port (10 mm) is inserted in the midline just below the liver 
edge or the costal margin, whichever is lower. The trocar is thrust in a rotatory 
movement so that it pierces the fascia and reaches the pre-peritoneal space. 
Then, it is turned right so that it enters the peritoneum at the base of the 
falciform ligament. This maneuver serves two purposes: (a) The trocar avoids 
injuring a vessel which sometimes runs in the free edge of the falciform 
ligament. (b) The instruments through this port do not suffer interference from 
a falciform ligament hanging in front ofthem. 
 
The mid-clavicular port (5 mm) is introduced at the same level, i.e., just 
below the liver edge or the costal margin, whichever is lower, right over the 
fundus of the gallbladder. 
 
The lateral most port (5 mm) is introduced at the same level and just 
anterior to the lateral peritoneal attachment of the ascending colon. 
 
Additional ports are sometimes required and may be placed as follows: 
 
A. Left lumbar 5 or 10 mm for three prong or flat blade retractor for downward 
traction of the colon, omentum and duodenum. This maneuver gives wide 
exposure of thehilum. 
B. 5 mm port midway between epigastric and right mid-clavicular ports for lifting 
the quadrate lobe using blunt tipped retractor, e.g. cirrhosis of the liver, left 
lobe gallbladder. 
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Figure 45: Port position for laparoscopic cholecystectomy 
 
2. Initialdissection: 
 
 
The fundus of the gallbladder is held with a ratcheted grasper and retracted 
by the assistant in a cranial direction, which lifts the right lobe of the liver and 
exposes the Calot’s triangle and hilum of the liver. 
 
Adhesions to the underside of the liver and gallbladder are carefully taken 
down beginning near the hilus and proceeding down towards the neck. The 
adhesions should be retracted downwards with the left hand grasper, to expose 
the plane of division. Adhesions may contain omentum, colon, stomach, and 
duodenum and hence must be dissected withcare. 
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Fig 46: Dissection of cystic duct   Figure 47: Dissection of cystic artery 
 
3. Dissection of cholecysto-hepatic triangle: 
 
 
An atraumatic (dolphin-nosed) non-locking grasper is introduced through 
the left hand working port to hold the infundibulum and retract it downwards 
and to the right. Thus, the hepatocystic triangle is widened and opened up and 
the structures are placed under tension. By retracting the infundibular grasper 
laterally, the anterior aspect of the Calot’s triangle is exposed. By retracting the 
infundibular grasper antero-medially, the posterior aspect of the Calot’s 
triangle is exposed. 
 
The dissection is begun on the infundibulum of the gallbladder. Using a 
Maryland’s forceps introduced through the epigastric port, the peritoneum of 
the infundibulum is held and breached by giving very small bursts of cautery 
current. By a combination of cautery and blunt dissection, the peritoneum on 
the anterior and posterior surface is stripped down patiently always being 
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careful to remain on the gallbladder side. The infundibular grasper is moved 
inferolaterally and superomedially (flagtechnique) to aid this dissection on the 
anterior and posterior surface of cholecysto-hepatic triangle respectively. The 
cholecysto-hepatic triangle is thus exposed. 
 
Fig 48: Dissection of cystic pedicle    Fig 49: Dissection of cystic duct by blunt 
dissection 
 
4. Identification of the cystic duct and artery: 
 
 
Now comes the most critical step of the operation - the identification of the 
cystic duct and artery. There are two well-described methods for ductal 
identification in laparoscopic cholecystectomy. 
 
The first method has been referred to as the “infundibular” or 
“infundibular- cystic” technique. In this method the cystic duct is isolated by 
dissection on the front and the back of the triangle of Calot and once isolated it 
is traced on to the gallbladder. Conclusive identification, i.e., the anatomic 
rationale for identification, occurs as a result of seeing the characteristic flare, 
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as the cystic duct widens to become the gallbladder infundibulum. Often this is 
referred to as seeing a funnel shape i.e. the gallbladder should be seen to funnel 
down to terminate in the cystic duct. The infundibular  method is the one 
usually found in texts describing the technique of laparoscopic 
cholecystectomy. 
 
The second method is the “critical view of safety” technique, which was 
described in 1995.[42] This method requires complete dissection of the  
cholecystohepatic triangle and separation of the base of the gallbladder 
infundibulum from the liver bed. The anatomic rationale for identification of 
the cystic structures results from the fact that there are two, and only two, 
structures entering the gallbladder, which is otherwise still attached only by the 
upper part of the liver bed. The triangle of Calot is dissected free of all tissue 
except for cystic duct and artery, and the base of the liver bed is exposed. 
When this view is achieved, the two structures entering the gallbladder can 
only be the cystic duct and artery. It is not necessary to see the common 
bileduct.[43] 
The cystic duct is identified at the junction with the gallbladder (safety 
zone) and followed down for an adequate length for cholangiography if 
desired. It is not always necessary to identify and dissect out the cystic-
common duct junction (danger zone). 
Cystic artery is identified along with its anterior and posterior branches by 
blunt dissection using curved dissector within the cystic triangle avoiding any 
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potential avulsion of the cystic artery off the right hepatic artery. The cystic 
node of Lund sometimes overlies the cystic artery. Attention is given to 
identify any unusual vascular or biliary tree anomalies. The main trunk of the 
cystic artery should be ligated and divided. Widely placed anterior and 
posterior branches areclipped individually and divided. Blind application of 
clips within the Calot’s triangle should be avoided. 
 
Both the cystic duct and the cystic artery are clipped, two clips on the cystic 
duct side and one clip on the gallbladder side. Though it is desirable to divide 
the artery before the duct, in selected situations, duct needs to be divided to 
expose cystic artery, hepatic artery, etc, and care is taken not to give excessive 
traction till the cystic artery is clipped and divided. 
 
 
Fig 50: Clipping of cystic artery               Fig 51: Clipping of cystic duct 
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5. Detachment of the gallbladder from the liver: 
 
 
The gallbladder can be detached from the liver bed using a variety of 
instruments - spatula with monopolar cautery, hook with monopolar cautery, 
scissors with monopolar cautery or Harmonic Scalpel. Surgeon’s experience 
and familiarity with a particular device is the most important aspect of 
choosing the best instrument for this purpose. 
Care should be taken to stay away from the porta hepatis and the liver bed 
and to avoid perforating the gallbladder. The infundibular grasper is used to 
elevate the gallbladder and alternately twist it to the left (medial rotation) and 
to the right (lateral rotation). A hook cautery is very useful for this phase of the 
operation. 
 
Prior to complete detachment of the gallbladder, the liver bed is inspected 
for adequate hemostasis or bile leak. The cystic duct remnant and cystic artery 
stumps are examined once again to ensure that the previously placed clips or 
sutures remain secure. Any minor oozing from the liver bed is controlled by 
application of cautery. After achieving hemostasis, the remaining separation is 
carried out and gallbladder is extracted. 
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Figure 52: Dissection of gallbladder from its bed 
 
 
6. Extraction of thegallbladder: 
 
 
The extraction of the gallbladder can be carried out through the umbilicus or 
the epigastric port. A claw-shaped gallbladder extraction forceps is introduced 
and used to grasp the neck of the gallbladder. The forceps, cannula and the 
neck of the gallbladder are pulled out of the     skin opening.If the gallbladder 
is too distended, the neck is opened and suction cannula is inserted to suck out 
the bile and if necessary, the stones are debulked through fragmentation by 
using a sponge holder. If the gallbladder is thick, preventing its extraction 
fascial incision is extended to facilitate its removal. 
 
7. Final inspection andirrigation: 
 
 
After gallbladder extraction, the epigastric port is replaced and the surgical 
site is inspected for bleeding. A thorough wash is given to the gallbladder bed, 
Morrison’s pouch, paracolic gutter and perihepatic areas with saline which is 
meticulously suctioned out. 
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8. Drainage andClosure: 
 
 
If a drain is needed, it can be placed through the lateral-most port. A size 
14F Romovac tube which goes through a 5 mm trocar is usually sufficient. If 
larger drainage tube is needed, it should be placed inside the peritoneal cavity 
through the epigastric port and brought out by a grasper through the lateral-
most port in a reverse fashion. 
 
The trocars are removed under direct vision to check that there is no 
bleeding from the trocar sites. Pneumoperitoneum is evacuated. The fascia of 
the 10 mm ports is closed with vicryl suture using port closure needle. Fascial 
closure is not required for the 5 mm ports. Skin closure is done using 3-0 vicryl 
subcuticular stitch/skinclip. 
 
  
Figure 44: Veress needle insertion            Figure 45: Port position for    
         laparoscopic cholecystectomy 
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COMPLICATIONS: 
1) Trocar injuries: 
2) Bleeding: 
3) Injury to bileducts: 
4) Stone and Bile spillage 
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METHODOLOGY 
The present study is a comparative study of 394 cases of 
cholelithiasis who undergone laparoscopic cholecystectomy in the 
institute of general surgery, MMC & RGGGH, Chennai, during study 
period of may 2017 to October 2018. These cases were selected based on 
inclusion criteria and were randomized using software after taking valid 
informed consent (Annexure) 
INCLUSION CRITERIA 
Adults > 18 years of age undergoing elective laparoscopic 
cholecystectomy for cholelithiasis 
EXCLUSION CRITERIA 
1. Cholangitis 
           2. Acute cholecystitis 
           3. Lap converted open cholecystectomy 
            4  Recent onset acute cholecystitis 
The general bio-data of patient regarding his name, age, sex, occupation, 
socio-economic status and address were collected. A detailed history was taken 
with special reference to duration of abdominal pain(RUQ pain or epigastric 
pain),dyspepsia, indigestion, its periodicity, its aggravation by fatty meals and 
relief by oral or parenteral analgesics. Any significant past history was also 
enquired. A relevant general physical examination, abdominal and systemic 
65 
examination was done. 
Pre-operative work up included a complete blood count, blood sugar, blood 
urea, serum creatinine, liver function tests, hepatitis profile, X-ray chest and 
ultrasound of abdomen. Ultrasonogram was routinely performed on all patients 
to confirm the clinical diagnosis of cholelithiasis with number of calculus and 
size of calculus, gall- bladder wall thickness (>4mm was considered 
abnormal), pericholecystic collection. 
A routine pre-anaesthetic checkup was done. A fully explained well 
informed consent was taken. A nasogastric tube was placed in all cases for 
gastric decompression to prevent trocar injury. All patients received 
prophylactic pre-op antibiotics (Inj. Cefotaxim 1gm IV). 
The patients were operated by different senior surgeons. The operation was 
performed with standard four port technique, using carbon dioxide for 
peritoneal cavity insufflation. The Veress technique was used to obtain 
pneumoperitoneum. Cystic artery and cystic duct were skeletinized and 
clamped with metallic clips separately. Following gall bladder removal, No.16 
romovac suction drain was placed in all cases. All patients had oral liquids 
followed by food from 3rd day after surgery, provided there was no nausea and 
vomiting. 
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RESULTS 
A total of 394  patients eligible for the study were selected. All the patients 
who undergone elective laparoscopic cholecystectomy categorised into study 
group and control group. Study group receiving prophylactic intravenous 
antibiotic (1gm cefotaxim) at the time of induction of anaesthesia alone. 
Control group receiving prophylactic intravenous antibiotic at the time of 
induction of anaesthesia which will be continued in the post operative period 
till discharge. Patients were followed in the post operative period with regard 
to surgical site infections. 
AGE INCIDENCE 
 Study group 
(N=197) 
Control group 
(N=197) 
 
Characteristics n % N % p value 
AGE (in 
years) 
30 to 39 98 49.7 117 59.4  
 
p<0.05 
 
40 to 49 68 34.5 60 30.5 
50 and above 31 15.7 20 10.2 
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 Mean age in the study group is 41 years, in the control group is 38 
years, the age group of patients ranges from 30 to 58 years. In study group 
49.7% of patients between 30 to 39 years of age.  In control group 59.4% of 
patients from 30 to 39 years of age. patients are allocated in the study and 
control without statistically significant. 
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SEX INCIDENCE: 
 
 
STUDY 
(N=197) 
CONTROL(N=19
7)  
Characteristics n % n % p value 
SEX 
Male 114 57.9 124 62.9 
p>0.05 
Female 83 42.1 73 37.1 
 
 
In the study group 114 cases(57.9%) are male and 83 cases (42.1%) are female 
. In the control group 124 cases (62.9%) are male and 73 cases (37.1%) are  
female. 
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COMORBIDITIES INCIDENCE: 
 
STUDY 
(N=197) 
CONTROL(N=197) 
 
Characteristics n % n % p value 
DIABETES 
MELLITUS 
Diabetic 25 12.7 29 14.7 
p<0.05 non 
diabetic 
172 87.3 168 85.3 
 
 
 
 
  
 
 
 
 
In the study group 25 patients are diabetic in the control group 29 patients are 
diabetic. When analysed statistically no significant association between the 
presence of diabetes and wound infection could be obtained.  
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Single dose 
(N=197) 
Multi dose 
(N=197)  
Characteristics N % n % p value 
Hypertension Hypertensive 19 9.6 11 5.6 p>0.05 
 
non 
hypertensive 
178 90.4 186 94.4 
 
 
 
 
 
 
  
         
 
In the study group 19 patients are hypertensive which is 9.6%. in the control 
group 11 patients are hypertensive which is 5.6%. when analysed statistically 
no significant association between the presence of hypertension and wound 
infection could be obtained 
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PRESENTING COMPLAINTS INCIDENCE: 
  STUDY 
(N=197) 
CONTROL 
(N=197) 
 
Characteristics N % N % p value 
presenting 
complaint 
abdominal 
pain 
157 79.7 128 65.0 p>0.05 
 Asymptomati
c 
10 5.1 42 21.3  
 Dyspepsia 30 15.2 26 13.2  
 Indigestion 0 0.0 1 0.5  
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Most of the patients are presented with abdominal pain  as a main 
complaint in both study and control group. 79.7% of patients in the study 
group 65% of patients in the control presented with abdominal pain.5.1% of 
patients in the study group and 21.3% of patients in the control group are 
asymptomatic.15.2% of patients in the study group, 13.2% of patients in the 
control group are presented with dyspepsia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
POST OPERATIVE COMPLICATIONS 
 
STUDY 
(N=197) 
CONTROL 
(N=197) 
 
N % N %  
Complications Developed 8 4.2 6 3.0 P<0.05 
 
not 
developed 
190 95.8 191 97.0 
 
 
 
 
STUDY(N=197) CONTROL(N=197) 
complication n % N % 
Fever 1 1.5 1 0.5 
Superficial 
infections (pus 
discharge from port 
site) 
7 3.6 5 2.5 
deep infection 0 0 0 0 
Seroma formation 0 0 0 0 
Others 0 0 0 0 
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Post operative complications are monitored. In study group 1 patient 
was developed fever, in the control group 1 patient developed fever.in this 
study surgical site infections were taken into account. In the study group 7 
patients (3.6%) developed pus discharge from port site which is considered as 
superficial infections ,in the control group 5 patients (2.5%) developed pus 
discharge. In all cases deep infections are ruled out by doing ultrasonography. 
There is no seroma formation in both study and control group. I concluded that 
surgical site infection in the single IV antiobiotic group is 3.6% where as in the 
control group, in which IV antibiotics were continued in the post operative 
period till discharge is 2.5%.  
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DISCUSSION 
    It is well documented that prophylactic antibiotic coverage of most 
‘clean contaminated’ surgical procedures can significantly prevent infectious 
complications, including wound infections, thereby affecting the overall 
mortality and morbidity. However the benefit of antibiotic prophylaxis in other 
‘clean surgical procedures, such as laparoscopic cholecystectomy, has been 
questionable. The low rate of wound infections and the straight forward 
treatment, if they occur at all, are the main arguments against routine antibiotic 
coverage during laparoscopic cholecystectomy. Laparoscopic cholecystectomy 
is an elective clean operations, and the post operative wound infections would 
be very low. Prophylaxis in clean operations has been shown to be of value in 
other areas of surgery such as trauma and vascular surgery but in laparoscopic 
cholecystectomy, its benefits remains uncertain. Due to the unknown impact on 
bacterial resistance, waldvogel and associates suggested that the routine use of 
antibiotic prophylaxis should be discouraged. 
The aim of the study was to assess the antibiotic therapy in preventing 
post -operative complications in laparoscopic cholecystectomy. The mean age 
of the study is 41 years in study group and 38 years in control group. The 
percentage of the females in the study group is 42.1% and in the control group 
is 37.1%. the percentage of males in the study group is 57.9% and in the 
control group is 62.9%. symptomatic cholelithiasis is most commontly present 
in the 5th decade with significant female prepondrence. Pain abdomen is was 
the commonest presenting symptom which occure 79.7% in the study group 
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and 65% in the control group. In my study 12.7% of patients in study group 
and 14.7% of patients in the control group were diabetic and 9.6% of patients 
in the study group and 5.6% of patients in the control group were hypertensive. 
There are several risk factors that are significantly associated with an increased 
incidence of infective complications in patients who undergo elective 
laparoscopic cholecystectomy, one of them is the presence of diabetic mellitus. 
Out of 197 patients in the study group 7 of them developed pus discharge from 
port site with incidence of about 3.6% and in the control group 5 patients out of 
197 patients are developed pus discharge from port site with incidence of about 
2.5%. all others had completely healed wound. These differences yielded a 
P>0.05 which is statistically insignificant, thereby illustrating that the rates of 
wound infection in patients given only a single shot of iv antiobiotic, and in 
patients given continuous post operative iv antibiotics is statistically 
insignificant.  
In a randomized controlled trial on 417 patients undergoing 
laparoscopic cholecysectomy, conducted by Gaur and Pujahari11, they 
reported an overall infection rate of 2.2 %, which is consistent with the results 
obtained in our study. All the infections healed before the availability of 
culture and sensitivity report without any specific therapy. 
Our findings are also similar to the findings obtained by Pokharel and 
associates12, who stated that the use of prophylactic antibiotics is a factor for 
lower incidence of post-operative infection following laparoscopic 
cholecystectomy. Good surgical techniques and the judicious use of 
77 
prophylactic antibiotics are two major factors for decreasing the incidence of 
septic complications after biliary tract surgery. 
In another study conducted by Mahmoud and associates to assess the 
role of antibiotic prophylaxis in elective laparoscopic cholecystectomy, they 
stated that antibiotic prophylaxis does not prevent wound infection in elective 
laparoscopic cholecystectomy. This is probably due to the fact that Mahmoud 
and associates excluded all patients with associated co-morbidities, like 
diabetes mellitus, hypertension etc. from their study. 
They also concluded that the use of antibiotic prophylaxis is preferred to 
be restricted to high-risk patients such as patients with associated co-
morbidities like diabetes mellitus. The rate of post-operative wound infection 
in our study was low (0.41%) and there was no significant difference between 
wound infection in patients receiving  prophylactic antibiotics and post-
operative antibiotics. This can be attributed to the following reasons. 
• Good surgical technique 
• Better handling of tissues 
• Strict adherence to aseptic precautions 
• Experienced laparoscopic surgeons 
In a study conducted by Gaur and Pujahari11, they concluded that the 
umbilicus is the commonest site for sepsis following laparoscopic 
cholecystectomy. This may be because the deep umbilical depression is 
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sometimes difficult to clean. Also, it may be due to the routine protocol of our 
unit to extract the gall bladder through the umbilical port. Colizza and 
associates14 also stated that the umbilicus is the commonest site for sepsis in 
elective laparoscopic choelcystectomy. 
In a study conducted by Koc and associates10, it was stated that the 
presence of diabetes mellitus is a risk factor for the development of 
postoperative infective complications in patients undergoing elective 
laparoscopic cholecystectomy. The presence of diabetes mellitus is a known 
risk factor for biliary sepsis. The altered motility of the common bile duct 
muscles, which is secondary to autonomic neuropathy observed in diabetic 
patients, as well as increased lipid concentration in bile, are the elements that 
can cause an increased susceptibility to biliary sepsis in patients with diabetes. 
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CONCLUSION 
 Based on the findings of our study, it may be concluded that post 
operative antibiotics do not reduce post-operative infective complications after 
elective laparoscopic cholecystectomy for cholelithiasis. One single dose of 
prophylactic antibiotic, administered at induction of anaesthesia, is sufficient to 
prevent post operative infective complications in patient undergoing elective 
laparoscopic cholecystectomy. 
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ANNEXURE 
INFORMATION SHEET 
TITLE :” A COMPARATIVE STUDY ON ELECTIVE 
LAPAROSCOPIC CHOLECYSTECTOMY WITH AND WITHOUT 
PROPHYLACTIC ANTIMICROBIAL THERAPY” 
Name of Investigator : Dr.A.SURESHKUMAR 
Name of Participant: 
Purpose of Research: A comparative study on elective laparoscopic 
cholecystectomy with and without antimicrobial therapy 
Study Design: Prospective study 
Study Procedure: Patient will be subjected to clinical examination ,Routine 
investigations, USG abdomen, CECT abdomen, Endoscopy. 
Prophylactic antibiotic IV dose  
Elective laparoscopic cholecystectomy 
Follow up 
Possible Risks: No risks to the patient 
Possible  benefits 
 We can avoid unnecessary use of  antibiotics and development of antibiotic 
resistance to the community. 
Confidentiality of the information obtained from you: The privacy of the 
patients in the research will be maintained throughout the study. In the event of 
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any publication or presentation resulting from the research, no personally 
identifiable information will be shared 
Can you decide to stop participating in the study: Taking part in this study is 
voluntary. You are free to decide whether to participate in this study or to 
withdraw at any time 
How will your decision to not participate in the study affect you: Your decision 
will not result in any loss of benefits to which you are otherwise entitled. 
 
Signature of Investigator     Signature of Participant 
 
Date : 
Place : 
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PATIENT CONSENT FORM 
 
 
 
 
 
 
Patient may check (☑) these boxes 
I confirm that I have understood the purpose of procedure for the above study. I 
have the opportunity to ask question and all my questions and doubts have 
been answered to my complete satisfaction. ❏ 
I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being 
affected. ❏ 
I understand that sponsor of the clinical study, others working on the sponsor’s 
behalf, the Ethics committee and the regulatory authorities will not need my 
permission to look at my health records, both in respect of current study and 
any further research that may be conducted in relation to it, even if I withdraw 
from the study I agree to this access. However, I understand that my identity 
will not be revealed in any information released to third parties or published, ❏ 
Study Detail : “A COMPARATIVE STUDY ON ELECTIVE 
LAPAROSCOPIC CHOLECYSTECTOMY WITH AND 
WITHOUT PROPHYLACTIC ANTIMICROBIAL 
THERAPY” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
90 
unless as required under the law. I agree not to restrict the use of any data or 
results that arise from this study. 
I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms. ❏ 
I hereby consent to participate in this study 
 
❏ 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological tests and 
to undergo treatment ❏ 
 
 
Signature/thumb impression  Signature of the Investigator 
Patient’s Name and Address: Study Investigator’s Name
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QUESTIONAIRE 
PATIENT DETAILS: 
Name:     Age:   Sex:   
 
IP No: 
 
ON ADMISSION: 
CHIEF  COMPLAINTS:  
 
DURATION: 
 
ASSOCIATED COMPLAINTS: 
 
CLINICAL EXAMINATION: 
Pulse :     BP : 
RR :      Temp : 
Pallor :     Icterus : 
CVS  :     RS : 
P/A :      CNS: 
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INVESTIGATIONS : 
HB%     
PCV      
TC     
RBC     
PLATELETS     
RBS     
Urea     
Creatinine     
Na+/K+     
 
 
 
 
 
 
 
CXR : 
USG ABDOMEN : 
LFT     
Total Bili     
Dir. Bili     
SGOT     
SGPT     
Total 
Protein 
    
Sr. Albumin     
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MAMMOGRAM : 
CECT ABDOMEN 
TREATMENT 
OPERATIVE MANAGEMENT : 
FOLLOW UP  : 
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